Heart Attack Diagnostic Market Global Competitive Landscape, Top Market Segments, And Fastest Growing Regions
23 May, 2023
The global heart attack diagnostics market size is expected to grow from $9.45 billion in 2022 to $10.27 billion in 2023 at a compound annual growth rate (CAGR) of 8.67%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The heart attack diagnostics market is expected to reach $13.38 billion in 2027 at a CAGR of 6.84%.
Global Heart Attack Diagnostic Market Key Driver
The rising prevalence of cardiac disorders is driving the growth of the heart attack diagnostics market. Cardiac disorders (CVD) are a group of heart and blood vessel problems that affect the heart. Heart disease and stroke are primarily caused by unhealthy eating, inactivity, tobacco use, and alcohol abuse. Heart attack diagnosis aids in determining the causes and severity of heart attacks, strokes, and heart failure. For instance, a World Health Organization (WHO) study from 2021 estimated that 17.9 million people worldwide died from cardiovascular diseases (CVDs), accounting for 32% of all deaths and 85% of these deaths were due to heart attacks and strokes. This shows the number of people getting cardiovascular disease (CVD) is steadily rising, including one-third of all deaths globally. Therefore, the rising frequency of cardiovascular illnesses will continue to drive the heart attack diagnostics market.
Get a sample of the global heart attack diagnostic market reportGlobal Heart Attack Diagnostic Market Segments
The global heart attack diagnostic market is segmented:
1) By Test Type: Electrocardiogram (ECG/EKG), Blood Tests, X-Ray, Echocardiogram, Coronary Catheterization (Angiogram), Exercise Stress Test, Magnetic Resonance Imaging (MRI)
2) By Procedure: Invasive Procedure, Non-Invasive Procedure
3) By End-Use Industry: Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users
4) By Geography: The regions covered in the heart attack diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global heart attack diagnostic market.
Major Heart Attack Diagnostic Industry Players
Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Hitachi Ltd., Koninklijke Philips NV, Midmark Corp., Siemens AG, Toshiba Corp., Welch Allyn Inc., Astrazenca PLC., HILL ROM HOLDINGS Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., Fujifilm Holdings, ACS Diagnostics Inc. and Beckman Coulter Inc.
Get the full global heart attack diagnostic industry report
Heart Attack Diagnostic Market Overview
Heart attack diagnostics are defined as the methods of identification, monitoring, screening, and prognosis that aid in validating the diagnosis of a heart attack and determining the type of heart attack a patient has had, which aids in determining the most effective treatment. Heart attack diagnostics are used to determine the presence of heart disease.
Heart Attack Diagnostic Global Market Report 2023 provides data on the global heart attack diagnostic market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The heart attack diagnostic market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.